Clinical Trial Update: Aqueous Humor Dynamics of NCX 470 Ophthalmic Solution [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 clinical trial updates for NCX 470 ophthalmic solution evaluating aqueous humor dynamics in open-angle glaucoma. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Open-angle Glaucoma

Drugs mentioned

• NCX 470 Ophthalmic Solution (NCX-470)

Snippet

Sponsor: Nicox Ophthalmics, Inc. | Conditions: Open Angle Glaucoma | Phase 2, Phase 3 | Status: COMPLETED